Javascript must be enabled to continue!
Brief of Amici Curiae Distinguished Economists on Rehearing En Banc in Support of the Appellee, TiVo Inc., in Favor of Affirmance in TiVo Inc. v. EchoStar Corp., et al.
View through CrossRef
EchoStar argues that the panel majority’s ruling (upholding the District Court's contempt proceeding ruling that EchoStar's attempted work around of an infringing device violated the court's injunction, and thus that EchoStar was in contempt of the order) will stifle innovation because fear of the “sword” of contempt will deter infringers from engaging in invention. In contrast, this brief of amici curiae shows that the much greater danger to innovation and the patent system will be caused by an infringer who is not willing to conform to the terms of a permanent injunction. In this case, contempt proceedings are appropriate, and the Federal Circuit should affirm its earlier ruling in favor of the Appellee, TiVo. It should do so by using a simple, analytical approach to contempt proceedings that is based on the doctrine of equivalents.
A trial court’s decision to enforce an injunction by issuing a contempt judgment depends on two prior steps: a determination that some expedited procedure focusing on compliance with the injunction is more appropriate than a subsequent new jury trial on the question of patent infringement, and a determination that contempt occurred. The overall process should satisfy several important objectives: (1) maintaining consistency with legal precedent, (2) fostering efficiency and due process, and (3) preserving incentives to invent, incentives to invest in and commercialize new technologies, and third-party incentives to avoid infringement and to design around. The combination of these objectives would be best satisfied if courts base their decisions on a doctrine of equivalents comparison between the newly accused device and the initial infringing device. Consistency, efficiency, fairness, and appropriate deterrence all demand that a newly accused device that is “equivalent” to the infringing device be adjudicated in a proceeding like contempt that affords both expedited process and the possibility of heightened penalties.
Title: Brief of Amici Curiae Distinguished Economists on Rehearing En Banc in Support of the Appellee, TiVo Inc., in Favor of Affirmance in TiVo Inc. v. EchoStar Corp., et al.
Description:
EchoStar argues that the panel majority’s ruling (upholding the District Court's contempt proceeding ruling that EchoStar's attempted work around of an infringing device violated the court's injunction, and thus that EchoStar was in contempt of the order) will stifle innovation because fear of the “sword” of contempt will deter infringers from engaging in invention.
In contrast, this brief of amici curiae shows that the much greater danger to innovation and the patent system will be caused by an infringer who is not willing to conform to the terms of a permanent injunction.
In this case, contempt proceedings are appropriate, and the Federal Circuit should affirm its earlier ruling in favor of the Appellee, TiVo.
It should do so by using a simple, analytical approach to contempt proceedings that is based on the doctrine of equivalents.
A trial court’s decision to enforce an injunction by issuing a contempt judgment depends on two prior steps: a determination that some expedited procedure focusing on compliance with the injunction is more appropriate than a subsequent new jury trial on the question of patent infringement, and a determination that contempt occurred.
The overall process should satisfy several important objectives: (1) maintaining consistency with legal precedent, (2) fostering efficiency and due process, and (3) preserving incentives to invent, incentives to invest in and commercialize new technologies, and third-party incentives to avoid infringement and to design around.
The combination of these objectives would be best satisfied if courts base their decisions on a doctrine of equivalents comparison between the newly accused device and the initial infringing device.
Consistency, efficiency, fairness, and appropriate deterrence all demand that a newly accused device that is “equivalent” to the infringing device be adjudicated in a proceeding like contempt that affords both expedited process and the possibility of heightened penalties.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Brief of Amici Curiae Professors Steven L. Schooner and Gregory C. Sisk in Support of Petitioners' Combined Petition for Panel Rehearing and Rehearing En Banc in Syneren Technologies Corp., et al, v. United States (U.S. Federal Circuit), April 6, 2026
Brief of Amici Curiae Professors Steven L. Schooner and Gregory C. Sisk in Support of Petitioners' Combined Petition for Panel Rehearing and Rehearing En Banc in Syneren Technologies Corp., et al, v. United States (U.S. Federal Circuit), April 6, 2026
This is an amicus brief in support of a petition for rehearing (and rehearing en banc) in Syneren Technologies Corp., et al, v. United States (No. 2024-1424). Amici are law profess...
Pengaruh Amicus Curiae (Sahabat Pengadilan) dalam Mempengaruhi Putusan Hakim menurut Sistem Peradilan Pidana
Pengaruh Amicus Curiae (Sahabat Pengadilan) dalam Mempengaruhi Putusan Hakim menurut Sistem Peradilan Pidana
Abstract. This research focuses on the regulation of Amicus Curiae in criminal procedural law in Indonesia and the influence of Amicus Curiae on judges' decisions in criminal justi...
Brief of Amici Curiae Family Law Professors in Support of Plaintiffs-Appellees and Affirmance in Kitchen v. Herbert
Brief of Amici Curiae Family Law Professors in Support of Plaintiffs-Appellees and Affirmance in Kitchen v. Herbert
This amici curiae brief was filed in the United States Circuit Court for the Tenth Circuit on behalf of 40 family and child welfare law professors in Kitchen v. Herbert, the federa...

